NASHUA, N.H., Aug. 02, 2021 (GLOBE NEWSWIRE) —

iCAD, Inc.

(NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, and Stacey Stevens, President, will participate in a fireside chat at the Guggenheim MedTech Disruptors Summit, taking place virtually on August 9-10, 2021.

Fireside Chat Details


Date: August 10, 2021

Time: 10:00am Eastern Time

About iCAD, Inc.


Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit

www.icadmed.com

.

Contact:


Media Inquiries:

Jessica Burns, iCAD

+1-201-423-4492

[email protected]

Investor Relations:

Jeremy Feffer, LifeSci Advisors

+ 1-212-915-2568

[email protected]